EV2-91331-06000
2 vaccinations
2 coded responses
25 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 530 / WI
- Registered
- 2022-12-01
- Relationship
- Child or adolescent in my care
- Guardian
- PTZ-25893-18962
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-12-01
Registered in v-safe
-
2022-12-01
Dose 1 — Moderna
- 2022-12-01
- 2022-12-02
- 2022-12-03
- 2022-12-04
- 2022-12-05
- 2022-12-06
- 2022-12-07
- 2022-12-08
- 2022-12-15
- 2022-12-22
- 2022-12-29
-
2023-01-05
Dose 2 — Moderna
- 2023-01-05
- 2023-01-06
- 2023-01-07
- 2023-01-08
- 2023-01-09
- 2023-01-10
- 2023-01-11
- 2023-01-12
-
2023-01-19
Survey response — day 14, dose 2, under 3MedDRA: Nasal congestion, Rhinorrhoea — Feeling: GoodMedDRA releases: 2024-11
- 2023-01-26
- 2023-02-02
- 2023-02-09
-
2023-02-16
Survey response — day 42, dose 2, under 3MedDRA: Cough, Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-04-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-12-01 | Moderna | No |
| 2 | 2023-01-05 | Moderna | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release